 immunotherapi antigen-induc eosinophil cell migrat nasal caviti effect immunotherapi IT eosinophil eo migrat nasal caviti nasal provoc ragwe antigen season exposur first studi group subject group treatment group month IT mainten microgram amb group month IT mainten microgram amb percent eoss nasal lavag decemb hour nasal challeng ragwe extract signific differ group challeng treatment group signific increas percent eoss treat group signific chang second studi patient group mainten dose microgram amb durat treatment treatment year microgram year microgram year microgram nasal mucos brush ragwe season percentag eoss it-treat individu control group versu dose IT durat reduct no-treat group